Hazel M Aker - Net Worth and Insider Trading
Hazel M Aker Net Worth
The estimated net worth of Hazel M Aker is at least $3,102 dollars as of 2024-11-13. Hazel M Aker is the Legal Counsel of Oncternal Therapeutics Inc and owns about 2,564 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $3,102. Details can be seen in Hazel M Aker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hazel M Aker has not made any transactions after 2020-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hazel M Aker
Hazel M Aker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hazel M Aker owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Hazel M Aker’s form 4 insider trades.
Insider Ownership Summary of Hazel M Aker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2020-07-21 | General Counsel |
Hazel M Aker Latest Holdings Summary
Hazel M Aker currently owns a total of 1 stock. Hazel M Aker owns 2,564 shares of Oncternal Therapeutics Inc (ONCT) as of July 21, 2020, with a value of $3,102.
Latest Holdings of Hazel M Aker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2020-07-21 | 2,564 | 1.21 | 3,102 |
Holding Weightings of Hazel M Aker
Hazel M Aker Form 4 Trading Tracker
According to the SEC Form 4 filings, Hazel M Aker has made a total of 1 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 2,099 shares on July 21, 2020, which cost Hazel M Aker around $99,893.
Insider Trading History of Hazel M Aker
- 1
Hazel M Aker Trading Performance
GuruFocus tracks the stock performance after each of Hazel M Aker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hazel M Aker is -34.25%. GuruFocus also compares Hazel M Aker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hazel M Aker within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hazel M Aker's insider trading performs compared to the benchmark.
Performance of Hazel M Aker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.91 | | | | | |
| Relative Return to S&P 500(%) | 1.62 | | | | | |
Hazel M Aker Ownership Network
Ownership Network List of Hazel M Aker
Ownership Network Relation of Hazel M Aker
Hazel M Aker Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Hazel M Aker is the General Counsel of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Hazel M Aker made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 28,000 shares made by Gunnar F. Kaufmann , and a net purchase of 980 shares made by David F Hale .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 12,380 shares were bought by its insiders, resulting in a net purchase of 11,400 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Hazel M Aker Mailing Address
Above is the net worth, insider trading, and ownership report for Hazel M Aker. You might contact Hazel M Aker via mailing address: C/o Cancer Vax Corp, 2110 Rutherford Road, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
